A Phase I trial of Goserelin Acetate extended release microspheres for injection for the treatment of carcinoma of the prostate and breast cancer.
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 06 Oct 2016
At a glance
- Drugs Goserelin (Primary)
- Indications Breast cancer; Prostate cancer
- Focus Adverse reactions
- 06 Oct 2016 New trial record
- 02 Sep 2016 This trial has been approved by United States Food and Drug Administration (USFDA), as reported by a Luye Pharma Group media release.